Aspeciallyformulatedcocktailofthreephosphataseinhibitorsthatwillinhibitalkalinephosphatasesandserine/threonineproteinphosphatasessuchasPP1andPP2A.B1aCellsEnhanceSusceptibilitytoInfectionwithVirulentFrancisellatularensisviaModulationofNK/NKTCellResponses.ThePresenceofCD14OvercomesEvasionofInnateImmuneResponsesbyVirulentFrancisellatularensisinHumanDendriticCellsInVitroandPulmonaryCellsInVivo.InvolvementofVitronectininLipopolysaccaride-InducedAcuteLungInjury.
Recommendedforusewithtissueandcellextracts,includingextractscontainingdetergents.Aspeciallyformulatedcocktailofthreephosphataseinhibitorsthatwillinhibitalkalinephosphatasesandserine/threonineproteinphosphatasessuchasPP1andPP2A.Eachvialcontains2.5mM(-)-p-bromotetramisoleoxalate,500uMcantharidinand500nMmicrocystin-LR
AdditionalInformation
| Product# | P-1517 |
|---|---|
| ChemicalName | PHOSPHATASEINHIBITORCOCKTAILI |
| Appearance | Clearcolorlessliquid.In1mlDMSO. |
| Preparation | Recommendedusageis100-folddilution |
| StorageTemp | -20°C |
| MDLNumber | MFCD01635520 |
|---|---|
| ChemACX | X1224363-9 |
